The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Dasatinib Drugs-Global Market Insights and Sales Trends 2025
Synopsis
Dasatinib, sold under the brand name Sprycel, is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).
The global Dasatinib Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dasatinib Drugs in various end use industries. The expanding demands from the CML and ALL, are propelling Dasatinib Drugs market. 20mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 50mg segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dasatinib Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dasatinib Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dasatinib Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dasatinib Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dasatinib Drugs covered in this report include Bristol-Myers Squibb and LUCIUS Pharma etc.
The global Dasatinib Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb
LUCIUS Pharma
Global Dasatinib Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dasatinib Drugs market, Segment by Type:
20mg
50mg
70mg
Global Dasatinib Drugs market, by Application
CML
ALL
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Dasatinib Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Dasatinib Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Dasatinib, sold under the brand name Sprycel, is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).
The global Dasatinib Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dasatinib Drugs in various end use industries. The expanding demands from the CML and ALL, are propelling Dasatinib Drugs market. 20mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 50mg segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dasatinib Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Dasatinib Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dasatinib Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dasatinib Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dasatinib Drugs covered in this report include Bristol-Myers Squibb and LUCIUS Pharma etc.
The global Dasatinib Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb
LUCIUS Pharma
Global Dasatinib Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dasatinib Drugs market, Segment by Type:
20mg
50mg
70mg
Global Dasatinib Drugs market, by Application
CML
ALL
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Dasatinib Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Dasatinib Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Dasatinib Drugs Market Overview
1.1 Dasatinib Drugs Product Overview
1.2 Dasatinib Drugs Market Segment by Type
1.2.1 20mg
1.2.2 50mg
1.2.3 70mg
1.3 Global Dasatinib Drugs Market Size by Type
1.3.1 Global Dasatinib Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Dasatinib Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Dasatinib Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Dasatinib Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Dasatinib Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Dasatinib Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Dasatinib Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Dasatinib Drugs Sales Breakdown by Type (2018-2023)
2 Global Dasatinib Drugs Market Competition by Company
2.1 Global Top Players by Dasatinib Drugs Sales (2018-2023)
2.2 Global Top Players by Dasatinib Drugs Revenue (2018-2023)
2.3 Global Top Players by Dasatinib Drugs Price (2018-2023)
2.4 Global Top Manufacturers Dasatinib Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Dasatinib Drugs Market Competitive Situation and Trends
2.5.1 Dasatinib Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Dasatinib Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dasatinib Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Dasatinib Drugs Market
2.8 Key Manufacturers Dasatinib Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Dasatinib Drugs Status and Outlook by Region
3.1 Global Dasatinib Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Dasatinib Drugs Historic Market Size by Region
3.2.1 Global Dasatinib Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Dasatinib Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Dasatinib Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Dasatinib Drugs Forecasted Market Size by Region
3.3.1 Global Dasatinib Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Dasatinib Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Dasatinib Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Dasatinib Drugs by Application
4.1 Dasatinib Drugs Market Segment by Application
4.1.1 CML
4.1.2 ALL
4.2 Global Dasatinib Drugs Market Size by Application
4.2.1 Global Dasatinib Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Dasatinib Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Dasatinib Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Dasatinib Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Dasatinib Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Dasatinib Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Dasatinib Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Dasatinib Drugs Sales Breakdown by Application (2018-2023)
5 North America Dasatinib Drugs by Country
5.1 North America Dasatinib Drugs Historic Market Size by Country
5.1.1 North America Dasatinib Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Dasatinib Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Dasatinib Drugs Sales in Value by Country (2018-2023)
5.2 North America Dasatinib Drugs Forecasted Market Size by Country
5.2.1 North America Dasatinib Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Dasatinib Drugs Sales in Value by Country (2024-2029)
6 Europe Dasatinib Drugs by Country
6.1 Europe Dasatinib Drugs Historic Market Size by Country
6.1.1 Europe Dasatinib Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Dasatinib Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Dasatinib Drugs Sales in Value by Country (2018-2023)
6.2 Europe Dasatinib Drugs Forecasted Market Size by Country
6.2.1 Europe Dasatinib Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Dasatinib Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Dasatinib Drugs by Region
7.1 Asia-Pacific Dasatinib Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Dasatinib Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Dasatinib Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Dasatinib Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Dasatinib Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Dasatinib Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Dasatinib Drugs Sales in Value by Region (2024-2029)
8 Latin America Dasatinib Drugs by Country
8.1 Latin America Dasatinib Drugs Historic Market Size by Country
8.1.1 Latin America Dasatinib Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Dasatinib Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Dasatinib Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Dasatinib Drugs Forecasted Market Size by Country
8.2.1 Latin America Dasatinib Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Dasatinib Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Dasatinib Drugs by Country
9.1 Middle East and Africa Dasatinib Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Dasatinib Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Dasatinib Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Dasatinib Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Dasatinib Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Dasatinib Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Dasatinib Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Company Information
10.1.2 Bristol-Myers Squibb Introduction and Business Overview
10.1.3 Bristol-Myers Squibb Dasatinib Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bristol-Myers Squibb Dasatinib Drugs Products Offered
10.1.5 Bristol-Myers Squibb Recent Development
10.2 LUCIUS Pharma
10.2.1 LUCIUS Pharma Company Information
10.2.2 LUCIUS Pharma Introduction and Business Overview
10.2.3 LUCIUS Pharma Dasatinib Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 LUCIUS Pharma Dasatinib Drugs Products Offered
10.2.5 LUCIUS Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Dasatinib Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Dasatinib Drugs Industrial Chain Analysis
11.4 Dasatinib Drugs Market Dynamics
11.4.1 Dasatinib Drugs Industry Trends
11.4.2 Dasatinib Drugs Market Drivers
11.4.3 Dasatinib Drugs Market Challenges
11.4.4 Dasatinib Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Dasatinib Drugs Distributors
12.3 Dasatinib Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
